KalVista Pharmaceuticals, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
KalVista Pharmaceuticals, Inc.
CIK #0001348911, 0001678087
EDGAR Form CIK 2011 - 2025
10-K [0001348911]
10-Q [0001348911]
3 [0001348911]
4 [0001348911]
8-K [0001348911]
D [0001348911]
SC 13D [0001348911]
SC 13G [0001348911]
SC 13D [0001678087]
Form 13D/13G Filer Form 13D/13G Subject Filed
Vestal Point Capital LP KalVista Pharmaceuticals Inc [2024-11-14]
Capital World Investors KalVista Pharmaceuticals Inc [2024-11-13]
Adage Capital Partners GP LLC KalVista Pharmaceuticals Inc [2024-02-26]
Vanguard Group Inc KalVista Pharmaceuticals Inc [2024-02-13]
Saturn V Capital Management LP KalVista Pharmaceuticals Inc [2024-02-12]
BlackRock Inc KalVista Pharmaceuticals Inc [2024-01-29]
Suvretta Capital Management LLC KalVista Pharmaceuticals Inc [2023-03-10]
FMR LLC KalVista Pharmaceuticals Inc [2023-02-09]
Venrock Healthcare Capital Partners III LP KalVista Pharmaceuticals Inc [2023-01-09]
TCG Crossover GP I LLC KalVista Pharmaceuticals Inc [2023-01-09]
Tang Capital Partners LP KalVista Pharmaceuticals Inc [2022-05-26]
Great Point Partners LLC KalVista Pharmaceuticals Inc [2022-05-18]
Franklin Resources Inc KalVista Pharmaceuticals Inc [2022-02-04]
Wellington Management Group LLP KalVista Pharmaceuticals Inc [2022-02-04]
Frazier Life Sciences Public Fund LP KalVista Pharmaceuticals Inc [2021-12-30]
Deep Track Capital LP KalVista Pharmaceuticals Inc [2021-10-25]
Suvretta Capital Management LLC KalVista Pharmaceuticals Inc [2021-09-17]
RA Capital Management LP KalVista Pharmaceuticals Inc [2021-05-27]
Flynn James E KalVista Pharmaceuticals Inc [2021-05-07]
BlackRock Inc KalVista Pharmaceuticals Inc [2021-02-02]
Ikarian Capital LLC KalVista Pharmaceuticals Inc [2020-03-23]
FMR LLC KalVista Pharmaceuticals Inc [2020-02-07]
Flynn James E KalVista Pharmaceuticals Inc [2019-04-19]
Vivo Ventures VI LLC KalVista Pharmaceuticals Inc [2018-09-12]
Venrock Healthcare Capital Partners II LP KalVista Pharmaceuticals Inc [2018-08-09]
Eventide Asset Management LLC KalVista Pharmaceuticals Inc [2018-02-12]
Longwood Fund II LP KalVista Pharmaceuticals Inc [2017-10-20]
Merck & Co Inc KalVista Pharmaceuticals Inc [2017-10-16]
RA Capital Management LLC KalVista Pharmaceuticals Inc [2017-02-14]
SVLSF IV LLC KalVista Pharmaceuticals Inc [2017-02-07]
Novo A/S KalVista Pharmaceuticals Inc [2016-11-30]
KalVista Pharmaceuticals Ltd Carbylan Therapeutics Inc [2016-06-27]
KalVista Pharmaceuticals Ltd Carbylan Therapeutics Inc [2016-06-27]
Franklin Resources Inc Carbylan Therapeutics Inc [2016-02-04]
Price T Rowe Associates Inc /MD/ Carbylan Therapeutics Inc [2015-05-11]
FMR LLC Carbylan Therapeutics Inc [2015-05-11]
ACP IV LP Carbylan Therapeutics Inc [2015-04-24]
Vivo Ventures VI LLC Carbylan Therapeutics Inc [2015-04-24]
InterWest Partners IX LP Carbylan Therapeutics Inc [2015-04-21]
Broadfin Capital LLC Carbylan Therapeutics Inc [2015-04-14]
Form 3/4/5 Subject 2011 - 2025
KalVista Pharmaceuticals, Inc.
Palleiko Benjamin L
Audhya Paul K.
Yea Christopher
Shah Nimish P
Koh Bong Y
Venrock Healthcare Capital Partners III, L.P.
VHCP Co-Investment Holdings III, LLC
VHCP Management III, LLC
VHCP Management EG, LLC
View All
Terms | Privacy | Guide
tony@aum13f.com